The extracellular matrix protein tenascin is secreted by osteoblasts b
ut absent from mineralized bone matrix. The current study was undertak
en to test the hypothesis that tenascin regulates osteoblast behaviour
. Three osteoblastlike cell lines UMR-106, ROS-17/2.8 (rat) and SAOS-2
(human) were used to investigate the role of tenascin in osteoblast m
orphology, differentiation and proliferation. Two of three cell lines
adhered specifically to tenascin, remaining round and failing to sprea
d. Tenascin as a substratum stimulated alkaline phosphatase activity (
a marker of osteoblast differentiation) in two of three cell lines. Mo
reover, anti-tenascin in the medium caused a reduction in alkaline pho
sphatase levels in all three cell lines. Antitenascin also inhibited c
ollagen synthesis, an important osteoblast function. Since it seemed p
ossible that tenascin may exert its effects on cell function through i
ts ability to cause cell rounding, the ability of cell shape change al
one to influence alkaline phosphatase levels was investigated. Cells w
ere incubated in the presence of cytochalasin D and alkaline phosphata
se levels assayed. Alkaline phosphatase activity was not elevated by c
ytochalasin D treatment, indicating that cell rounding alone is insuff
icient to mimic the effect of tenascin. Anti-tenascin caused a slight
increase in proliferation of SAOS-2 cells, indicating that tenascin is
itself inhibitory. In ROS 17/2.8 and UMR-106 cells, in contrast, prol
iferation was inhibited by anti-tenascin. The results presented here i
ndicate that tenascin is able to stimulate osteoblastic differentiatio
n and that endogenous tenascin helps to maintain the functional state
of cultured osteoblast-like cells.